Telix Pharmaceuticals (ASX:TLX) has announced that the last patient has been imaged in a phase one clinical study of the company's investigational prostate cancer imaging product TLX591-CDx. …
Telix Japanese prostate cancer imaging study completes enrolment
September 9, 2021 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
Medicines Australia calls for Budget action to restore access to innovative medicines
February 3, 2026 - - Latest News -
Survey exposes deep gaps in support for Australians living with rare cancers
February 3, 2026 - - Latest News -
Juvenile Arthritis Foundation Australia seeks new CEO as Angela McKay steps down
February 3, 2026 - - Latest News -
AusBiotech and Medicines Australia unite to accelerate advanced therapies
February 3, 2026 - - Latest News -
If you're going to pay for reforms, are these the changes you want to pay for?
February 3, 2026 - - Latest News -
Arthritis Australia appoints Louise Hardy as CEO at pivotal moment for national advocacy
February 2, 2026 - - Latest News -
AusBiotech urges adoption of national life sciences strategy as global competition intensifies
February 2, 2026 - - Australian Biotech